AVIBACTAM SODIUM; CEFTAZIDIME | N206494 | ABBVIE INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
AbbVie Inc. et al v. Fresenius Kabi USA, LLC et al 7 patentsANDA 219325ceftazidime and avibactam | D.N.J. | 2025-03-03 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 7112592 | Jan 7, 2026 | — | Yes | Yes | — | |
| 7112592 | Jan 7, 2026 | — | Yes | Yes | — | |
| 7112592 | Jan 7, 2026 | — | Yes | Yes | — | |
| 7112592 | Jan 7, 2026 | — | Yes | Yes | — | |
| 7612087 | Nov 12, 2026 | — | — | Yes | — | — |
| 8471025 | Aug 12, 2031 | — | Yes | — | — | — |
| 8835455 | Oct 8, 2030 | — | — | Yes | — | — |
| 8969566 | Jun 15, 2032 | — | Yes | — | — | — |
| 9284314 | Jun 15, 2032 | — | Yes | — | — | — |
| 9695122 | Jun 15, 2032 | — | Yes | — | — | — |
| Code | Date | Status |
|---|---|---|
| NPP | Jan 26, 2027 | < 1 year |